GALR1 and PENK serve as potential biomarkers in invasive non-functional pituitary neuroendocrine tumours

被引:0
|
作者
Wu, Zerui [1 ,2 ]
Rao, Changjun [3 ,4 ]
Xie, Yilin [1 ,2 ]
Ye, Zhen [1 ,2 ]
Zhang, Yichao [1 ,2 ]
Ma, Zengyi [1 ,2 ]
Su, Zhipeng [4 ]
Ye, Zhao [1 ,2 ]
机构
[1] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Neurosurg, Shanghai 200040, Peoples R China
[2] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Natl Ctr Neurol Disorders, Shanghai 200040, Peoples R China
[3] Capital Med Univ, Beijing Neurosurg Inst, Dept Cell Biol, Beijing, Peoples R China
[4] Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurosurg, Wenzhou, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Pituitary tumors; Invasion; GLAR1; PENK; GALANIN RECEPTOR-1; GENE; EXPRESSION; EPIDEMIOLOGY; ADENOMAS;
D O I
10.1016/j.gene.2025.149374
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Some nonfunctioning pituitary neuroendocrine tumor (NFPitNET) can show invasive growth, which increases the difficulty of surgery and indicates a poor prognosis. However, the molecular mechanism related to invasiveness remains to be further studied. This study is to screen and identify the characteristic biomarkers of invasive NFPitNETs. Methods: Based on the data of 73 NFPitNETs microarray chips in the GSE169498 dataset, this study used weighted gene co-expression network (WGCNA), differential expression analysis, protein-protein interaction (PPI) network analysis and various machine learning methods (XGBOOST, LASSO regression, random forest, support vector machine) to screen candidate biomarkers for invasive NFPitNET. Then, using gene set enrichment analysis (GSEA) to explore the differences in biological activities and signaling pathways between invasive NFPitNET and non-invasive NFPitNET. Single-sample GSEA (ssGSEA) was used to analyze key biomarkersrelated signaling pathways. Finally, the expression and function of the key biomarkers were verified by q-RT PCR, immunohistochemical (IHC) experiments and in vitro experiments. Results: Combined with WGCNA and differential expression analysis, 128 high-expression and 85 low-expression candidate biomarkers were preliminarily obtained. PPI analysis and four machine learning algorithms further identified GALR1, PENK and HOXD9. The receiver operating characteristic (ROC) curve results showed that the three biomarkers had good predictive ability of invasiveness. After combining the validation set data, GALR1 and PENK were the final key biomarkers. Finally, PCR and IHC results verified the decreased expression of GALR1 and PENK in invasive NFPitNET and promotes proliferation and invasive ablity of pituitary tumor cells. Conclusion: This study confirmed that the reduced expression of GALR1 and PENK is an important molecular feature of invasive NFPitNETs, which may play an important role in inhibiting the development of NFPitNET.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Differential proteomic expression in non-functional pituitary neuroendocrine tumours and pituitary glands
    Candy, Nicholas G.
    Ramezanpour, Mahnaz
    Bouras, George
    Chegeni, Nusha
    Chataway, Timothy
    Ormsby, Rebecca J.
    Jukes, Alistair K.
    Vreugde, Sarah
    Wormald, Peter-John
    Psaltis, Alkis J.
    RHINOLOGY, 2024, 62 (06) : 750 - 758
  • [2] Potential biomarkers of miRNA in non-functional pituitary adenomas
    Zhang, Qizhi
    Wang, Ying
    Zhou, Yinting
    Zhang, Qiujuan
    Xu, Chuan
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [3] Potential biomarkers of miRNA in non-functional pituitary adenomas
    Qizhi Zhang
    Ying Wang
    Yinting Zhou
    Qiujuan Zhang
    Chuan Xu
    World Journal of Surgical Oncology, 19
  • [4] Diagnosis of invasive non-functional pituitary adenomas using exosomal biomarkers
    Ren, Yuan
    Wang, Ying
    Bao, Xinjie
    Feng, Ming
    Xing, Bing
    Lian, Wei
    Yao, Yong
    Wang, Renzhi
    CLINICA CHIMICA ACTA, 2022, 529 : 25 - 33
  • [5] Predicting survival in non-functional pancreatic neuroendocrine tumours
    Tan, Qing-Quan
    Wang, Xing
    Yang, Le
    Chen, Yong-Hua
    Tan, Chun-Lu
    Ke, Neng-Wen
    Liu, Xu-Bao
    ANZ JOURNAL OF SURGERY, 2020, 90 (10) : 2026 - 2031
  • [6] Non-functional pituitary neuroendocrine tumours (NF-PitNETs): an algerian series of 84 cases
    Lounis, K.
    Bouzid, N.
    Younes, S. Ait
    VIRCHOWS ARCHIV, 2024, 485 : S104 - S104
  • [7] Management and surveillance of non-functional pancreatic neuroendocrine tumours: Retrospective review
    Yohanathan, Lavanya
    Dossa, Fahima
    St Germain, Amelie Tremblay
    Golbafian, Faegheh
    Moulton, Carol-anne
    McGilvray, Ian D.
    Greig, Paul D.
    Serra, Stefano
    Wei, Alice C.
    Jhaveri, Kartik S.
    Gallinger, Steve
    Cleary, Sean P.
    PANCREATOLOGY, 2019, 19 (02) : 360 - 366
  • [8] Outcome after laparoscopic enucleation for non-functional neuroendocrine pancreatic tumours
    Fernandez-Cruz, Laureano
    Molina, Victor
    Vallejos, Rodrigo
    Jimenez Chavarria, Enrique
    Lopez-Boado, Miguel-Angel
    Ferrer, Joana
    HPB, 2012, 14 (03) : 171 - 176
  • [9] Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality
    Wu, Junjun
    Sun, Chi
    Li, Enliang
    Wang, Jiakun
    He, Xianping
    Yuan, Rongfa
    Yi, Chenghao
    Liao, Wenjun
    Wu, Linquan
    BMC CANCER, 2019, 19 (1)
  • [10] Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality
    Junjun Wu
    Chi Sun
    Enliang Li
    Jiakun Wang
    Xianping He
    Rongfa Yuan
    Chenghao Yi
    Wenjun Liao
    Linquan Wu
    BMC Cancer, 19